Brief Behavioral Health Intervention Program for Patients With Stable Coronary Artery Disease

Completed · Not applicable

Conditions studied: Coronary Artery Disease, Ischemic Heart Disease, Coronary Heart Disease

In brief

The purpose of this study is to examine the effectiveness of a lifestyle intervention for patients living with stable coronary artery disease (CAD). One group will receive the the intervention, and the other will receive treatment as usual (TAU). The investigators hypothesize that, compared to the TAU group, participants receiving the intervention will 1) experience greater confidence in managing their cardiac disease, as indicated by perceived self-efficacy and illness perceptions; 2) experience greater psychological adjustment as indicated by depressive, anxious, and demoralization symptoms; 3) experience greater engagement in health behaviors including healthy eating and physical activity.

Key facts

Study ID

NCT03629158

Run by

University of Central Florida

People needed

33

Starts

2018-09-11

Expected to finish

2019-07-09

Last updated by the study team

2019-08-02

Who can join

Age: 30 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• CAD as indicated by history of at least one myocardial infarction, at least one coronary artery bypass graft surgery, at least one coronary stent, and/or at least one coronary vessel with stenosis greater than or equal to 70%.
• Stable status as indicated by no myocardial infarctions, unstable angina, or other acute coronary syndromes within the past 3 months, no coronary revascularizations within the past 3 months, and no planned revascularizations.

You may not qualify if…

• Age < 30 years or > 79 years
• Cognitive impairment as indicated by diagnosis in medical chart
• Psychotic symptoms as indicated by diagnosis in medical chart
• Any documented non-skin malignancy, malignant melanoma, or advanced kidney disease (indicated by stage 4 or 5 or on dialysis)
• Ejection fraction < 30%
• Physician determination of inappropriateness for study, due to anticipated life expectancy of <1 year, presence of a survival limiting or uncontrolled illness, and/or hemodynamically important valvular disease.
• Women who are pregnant or breast feeding
• Non-English-speaking
• Participation in another clinical trial concurrently or within 30 days before screening
• Psychological safety concerns, including plans to harm oneself within the past two months and/or suicide attempt within the past year

Where it is running

• UCF Health — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.